Decreased Expression of T-Cell Costimulatory Molecule CD28 on CD4 and CD8 T Cells of Mexican Patients with Pulmonary Tuberculosis
Author(s) -
Germán Bernal-Fernández,
Patricia Espinosa-Cueto,
Rosario Leyva-Meza,
Nathalie Mancilla,
Raúl Mancilla
Publication year - 2010
Publication title -
tuberculosis research and treatment
Language(s) - English
Resource type - Journals
eISSN - 2090-1518
pISSN - 2090-150X
DOI - 10.1155/2010/517547
Subject(s) - cd28 , cd8 , medicine , immunology , t cell , cytotoxic t cell , downregulation and upregulation , immune system , cancer research , biology , in vitro , biochemistry , gene
Patients with tuberculosis frequently develop anergy, a state of T-cell hyporesponsiveness in which defective T-cell costimulation could be a factor. To know if the expression of T-cell costimulatory molecules was altered in tuberculosis, we analyzed the peripheral blood T-cell phenotype of 23 Mexican patients with pulmonary tuberculosis. There was severe CD4 ( P < .001) and CD8 ( P < .01) lymphopenia and upregulation of costimulatory molecule CD30 on CD4 and CD8 T cells ( P < .05); this increase was higher in relapsing tuberculosis. The main finding was severe downregulation of the major costimulatory molecule CD28 on both CD8 and CD4 T cells ( P < .001). Depletion of the CD4/CD28 subset, a hitherto undescribed finding, is relevant because CD4 T cells constitute the main arm of the cell-mediated antimycobacterial immune response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom